Shri JB Pharma Private Limited
About Shri JB Pharma Private Limited
Data last updated:
Shri JB Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 09 May 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U21001MH2023PTC402579.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Govardhan Murlidhar Dhoot and Radhika Ajay Dhoot.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹51.63 Lakh, a growth of 99% compared to the previous year. For the same year it recorded a net profit of ₹3.14 Lakh (net margin 6.1%) and EBITDA of ₹4.38 Lakh (EBITDA margin 8.5%).
As per MCA filings, the company has open charges of ₹8 Cr on record. Court records list 3 cases involving the company, including 3 filed against it; 3 cases are pending.
Company details
Contact details
Shri JB Pharma Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address3rd Floor Rupam Building, 239 P D Mello Road Near G.P.O., Mumbai, Maharashtra, India – 400001
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shri JB Pharma is manufacturing. In detail, this covers manufacture of food products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 10 | Manufacture of food products |
To see the full business activity and turnover split of Shri JB Pharma Private Limited, buy the company report.
Financials of Shri JB Pharma Private Limited
FY 2025 filings availableShri JB Pharma Private Limited reported revenue of ₹51.63 Lakh (up 99% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 99% in the latest year. EBITDA rose 578% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹4.38 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹3.14 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 8.5% | |
| Net Profit Margin | 6.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Shri JB Pharma Private Limited, buy the company report.
Board of directors of Shri JB Pharma Private Limited
Shri JB Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Govardhan Murlidhar Dhoot Also directs: Mangalam Drugs and Organics Limited | Director | 09 May 2023 | 3 Years 5 Months | Current |
| Radhika Ajay Dhoot Also directs: Universal Transformers Private Limited, Raj Exports Private Limited, Shree Rasbihari Trading and Investments Pvt Ltd and 1 more | Director | 09 May 2023 | 3 Years 5 Months | Current |
| Smita Aditya Dhoot | Director | 09 May 2023 | 3 Years 5 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Jul 2025 | 101140685 | Others | ₹8 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Shri JB Pharma Private Limited has 3 court cases on record: 3 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 3 |
Cases on record (1 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMARY CASE) | Filed against the company by Tata Capital Limited TCL Through Authorised Representative Mr Ameet Suneel Deosthale and 1 other | Pending |
To see the full case history of Shri JB Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shri JB Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Shri JB Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Shri JB Pharma Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Govardhan Murlidhar Dhoot was appointed as Director on 09 May 2023.
Frequently asked questions
Shri JB Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in paper and paper products, within the paper industry. It was incorporated on 09 May 2023 (3+ years old) and is registered under CIN U21001MH2023PTC402579.
Shri JB Pharma has 3 current directors:
- Govardhan Murlidhar Dhoot - Director
- Radhika Ajay Dhoot - Director
- Smita Aditya Dhoot - Director
The latest financial statements of Shri JB Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Shri JB Pharma is U21001MH2023PTC402579. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shri JB Pharma has 3 court cases on record: 3 filed against it. 3 are pending.
Shri JB Pharma was incorporated on 09 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
Govardhan Murlidhar Dhoot was appointed as Director on 09 May 2023. Radhika Ajay Dhoot was appointed as Director on 09 May 2023. Smita Aditya Dhoot was appointed as Director on 09 May 2023.
The registered office of Shri JB Pharma is at 3rd Floor Rupam Building, 239 P D Mello Road Near G.P.O., Mumbai, Maharashtra, India – 400001.
Shri JB Pharma operates in the paper industry, in the paper and paper products segment.
Shri JB Pharma has open charges of ₹8 Cr and no satisfied charges on record as per latest MCA filings.